Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Inmaculada Ramos"'
Autor:
Inmaculada Ramos-Lerate, Rafael Lozano-Bermejo, Juan Ignacio Burneo, Chabaco Armijos, Manuel Piñero, Juan Pedro Bolívar, Manuel Jesús Gázquez
Publikováno v:
Journal of Agriculture and Food Research, Vol 17, Iss , Pp 101236- (2024)
The radiological background in soils across various areas in Southern Ecuador, such as Vilcabamba, Loja, Palanda, Catamayo, and Taquil, was studied to understand the impact of agriculture and fertilizer usage on soil radiological composition. Areas i
Externí odkaz:
https://doaj.org/article/3e230ad3804741ef97a6e91e93e4415f
Autor:
Federico Rojo, Esther Conde, Héctor Torres, Luis Cabezón-Gutiérrez, Dolores Bautista, Inmaculada Ramos, David Carcedo, Natalia Arrabal, J. Francisco García, Raquel Galán, Ernest Nadal
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Detection of the ROS1 rearrangement is mandatory in patients with advanced or metastatic non-small cell lung cancer (NSCLC) to allow targeted therapy with specific inhibitors. However, in Spanish clinical practice ROS1 determinati
Externí odkaz:
https://doaj.org/article/b12bf91cf97542918d4058024d765d32
Autor:
Manuel Jesús, Gázquez, Daniela Carolina, Paz Gómez, José Juan, Alonso, Silvia María, Pérez-Moreno, Inmaculada, Ramos-Lerate, Melquiades Casas-, Ruiz, Juan Pedro, Bolívar
Publikováno v:
Talanta. 253
This report presents a new methodology to isolate and measure
Autor:
Maria Garrido-Barros, Javier Oliver, Juan Luis Onieva, Beatriz Martinez-Galvez, Jaime Duddelman, Antonio Rueda, Elisabeth Perez, Emilio Alba, Inmaculada Ramos, Juan Zafra, Manuel Cobo, Isabel Barragán
Publikováno v:
Cancer Research. 83:3746-3746
Immunotherapy based on Immune Checkpoint blockade (ICB) has become a significant therapeutic option for advanced Non Small Cell Lung Cancer (NSCLC) patients. However, there is an urgent need to find novel biomarkers that to reliably stratify good res
Autor:
Manuel Jesús Gázquez, Daniela Carolina Paz Gómez, José Juan Alonso, Silvia María Pérez-Moreno, Inmaculada Ramos-Lerate, Melquiades Casas- Ruiz, Juan Pedro Bolívar
Publikováno v:
Talanta. 253:123972
Autor:
Federico Rojo, Esther Conde, Héctor Torres, Luis Cabezón-Gutiérrez, Dolores Bautista, Inmaculada Ramos, David Carcedo, Natalia Arrabal, J. Francisco García, Raquel Galán, Ernest Nadal
Background: Detection of the ROS1 rearrangement is mandatory in patients with advanced or metastatic non-small cell lung cancer (NSCLC) to allow targeted therapy with specific inhibitors. However, in Spanish clinical practice ROS1 determination is no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0fabf075d1706997529b343135f8f705
https://doi.org/10.21203/rs.3.rs-1103970/v1
https://doi.org/10.21203/rs.3.rs-1103970/v1
Autor:
Esperanza Torres, Emilio Alba, M. Cobo, Inmaculada Ramos, Ana Godoy, Laura Galvez, Nuria Ribelles, Sofia Ruiz-Medina, Begoña Jimenez, Marta Muñoz-Ayllon, Pablo Rodriguez-Brazzarola, Mireya Cazorla, María José Bermejo, Tamara Diaz-Redondo, Antonio Rueda, Carmen Reyna, Silvia Gil
Publikováno v:
Cancers
Volume 13
Issue 13
Cancers, Vol 13, Iss 3215, p 3215 (2021)
Volume 13
Issue 13
Cancers, Vol 13, Iss 3215, p 3215 (2021)
The COVID-19 pandemic has caused a profound change in health organizations at both the primary and hospital care levels. This cross-sectional study aims to investigate the impact of the COVID-19 pandemic in the annual rate of new cancer diagnosis in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f95f9af8d8add2d755a1ac8d7af293f
https://hdl.handle.net/10668/18094
https://hdl.handle.net/10668/18094
Autor:
Manuel Espeso, Inmaculada Ramos, Antonio Rueda, Ángeles Medina, Emilio Alba, Jose Reinaldo Chícharo, Cristina Quero, María José Casanova, Laura Galvez-Carvajal, Carola Díaz
Publikováno v:
International journal of hematology. 115(1)
Up to 25% of patients with classical Hodgkin lymphoma (cHL) and a negative interim PET/CT will progress. Unfortunately, there are few published studies on the predictive value of PET/CT performed after finishing treatment. The objective of our study
Autor:
Marina Chiara Garassino, Byoung-Chul Cho, Joo-Hang Kim, Julien Mazières, Johan Vansteenkiste, Hervé Lena, Jesus Corral Jaime, Jhanelle E Gray, John Powderly, Christos Chouaid, Paolo Bidoli, Paul Wheatley-Price, Keunchil Park, Ross A Soo, Yifan Huang, Catherine Wadsworth, Phillip A Dennis, Naiyer A Rizvi, Luis Paz-Ares Rodriguez, Silvia Novello, Sandrine Hiret, Peter Schmid, Eckart Laack, Raffaele Califano, Makoto Maemondo, Sang-We Kim, Jamie Chaft, David Vicente Baz, Thierry Berghmans, Dong-Wan Kim, Veerle Surmont, Martin Reck, Ji-Youn Han, Esther Holgado Martin, Cristobal Belda Iniesta, Yuichiro Oe, Antonio Chella, Akhil Chopra, Gilles Robinet, Hector Soto Parra, Michael Thomas, Parneet Cheema, Nobuyuki Katakami, Wu-Chou Su, Young-Chul Kim, Juergen Wolf, Jong-Seok Lee, Hideo Saka, Michele Milella, Inmaculada Ramos Garcia, Anne Sibille, Takashi Yokoi, Eun Joo Kang, Shinji Atagi, Ernst Spaeth-Schwalbe, Makoto Nishio, Fumio Imamura, Nashat Gabrail, Remi Veillon, Sofie Derijcke, Tadashi Maeda, Dylan Zylla, Kendra Kubiak, Armando Santoro, Ma. Noemi Uy, Sarayut Lucien Geater, Antoine Italiano, Dariusz Kowalski, Fabrice Barlesi, Yuh-Min Chen, David Spigel, Busyamas Chewaskulyong, Ramon Garcia Gomez, Rosa Alvarez Alvarez, Chih-Hsin Yang, Te-Chun Hsia, Fabrice Denis, Hiroshi Sakai, Mark Vincent, Koichi Goto, Joaquim Bosch-Barrera, Glen Weiss, Jean-Luc Canon, Christian Scholz, Massimo Aglietta, Hirotsugu Kemmotsu, Koichi Azuma, Penelope Bradbury, Ronald Feld, Abraham Chachoua, Jacek Jassem, Rosalyn Juergens, Ramon Palmero Sanchez, Albert Malcolm, Nandagopal Vrindavanam, Kaoru Kubota, Cornelius Waller, David Waterhouse, Bruno Coudert, Zsuzsanna Mark, Miyako Satouchi, Gee-Chen Chang, Christian Herzmann, Arvind Chaudhry, Selvaraj Giridharan, Paul Hesketh, Norihiko Ikeda, Ralph Boccia, Nichola Iannotti, Missak Haigentz, John Reynolds, John Querol, Kazuhiko Nakagawa, Shunichi Sugawara, Eng Huat Tan, Tomonori Hirashima, Scott Gettinger, Terufumi Kato, Koji Takeda, Oscar Juan Vidal, Andrea Mohn-Staudner, Amit Panwalkar, Davey Daniel, Kunihiko Kobayashi, Guia Elena Imelda Ladrera, Clemens Schulte, Martin Sebastian, Marketa Cernovska, Helena Coupkova, Libor Havel, Norbert Pauk, Joginder Singh, Shuji Murakami, Tibor Csoszi, Gyorgy Losonczy, Allan Price, Ian Anderson, Mussawar Iqbal, Vamsee Torri, Erzsebet Juhasz, Saleem Khanani, Leona Koubkova, Benjamin Levy, Ray Page, Csaba Bocskei, Lucio Crinò, David Einspahr, Christopher Hagenstad, Necy Juat, Lindsay Overton, Mitchell Garrison, Zsuzsanna Szalai
Publikováno v:
Lancet Oncology
Lancet Oncology, 2020, 19 (4), pp.521-536. ⟨10.1016/s1470-2045(18)30144-x⟩
Lancet Oncol
Lancet Oncology, 2020, 19 (4), pp.521-536. ⟨10.1016/s1470-2045(18)30144-x⟩
Lancet Oncol
Background: Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC) without EGFR tyrosine kinase or anaplastic lymphoma kinase (ALK) genetic aberrations (EGFR−/ALK−), but clinical bene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00025c91c5f85bf7d8b98d17aae85fd1
https://hal.u-pec.fr/hal-04145965/document
https://hal.u-pec.fr/hal-04145965/document
Autor:
Edurne Arriola, Raquel Marsé, Victor Diaz, Dolores Isla, Silvia Catot, María Sereno, Antonio Calles, A. Martinez, Luis Cabezón, Nuria Viñolas, Carlos Aguado, Joaquim Bosch, Inmaculada Ramos, Jose Miguel Sanchez Torres, Paloma Martín Martorell, Manuel Domine, Álvaro Taus, Oscar Juan, Georgia Anguera, Ramon Palmero, Ana Gómez Rueda, Silvia Muñoz, Susana Cedres, Teresa Moran
Publikováno v:
Clinical lung cancer. 21(5)
Introduction Uncommon epidermal growth factor receptor (EGFR) mutations (u-EGFRm) are a heterogeneous group of molecular alterations and have also been reported as comutations with other EGFR mutations (complex mutations) in non–small-cell lung can